Back to Newsroom

Novira Names Christian S. Schade Chief Executive Officer

DOYLESTOWN, Pa., March 19, 2014 — Novira Therapeutics, Inc., today announced that Christian S. Schade has been named Chief Executive Officer, effective March 19.

Mr. Schade has more than 30 years of extensive private and public pharmaceutical and biotechnology industry experience as well as broad capital markets experience from his tenure in the investment banking industry. Prior to joining Novira he was Executive Vice President and Chief Financial Officer of Omthera Pharmaceuticals where he played a lead role in taking the company public and in the sale of the company to AstraZeneca Plc., which closed in July 2013.